
Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m2) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
Keywords: شیمیدرمانی نئوادجوانت; Breast cancer; Nab-paclitaxel; Neoadjuvant chemotherapy; Peripheral neuropathy; Phase II;